Nomura Holdings
SNDX icon

Nomura Holdings’s Syndax Pharmaceuticals SNDX Stock Holding History

Nomura Holdings’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Sell
18,000
-20,000
-53% -$435K ﹤0.01% 1414
2025
Q4 		$798K Buy
+38,000
New +$663K ﹤0.01% 1407
2025
Q3 		– Sell
-27,000
Closed -$253K – 2064
2025
Q2 		$253K Hold
27,000
– – ﹤0.01% 1268
2025
Q1 		$332K Buy
+27,000
New +$381K ﹤0.01% 1584
2024
Q4 		– Sell
-40,000
Closed -$770K – 2384
2024
Q3 		$770K Buy
+40,000
New +$826K ﹤0.01% 1175

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Nomura Holdings's SNDX Position: Q4 2024 in Review

Nomura Holdings sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 21,849 shares — an estimated $421K sold.

Nomura Holdings first reported a position in SNDX in Q3 2024 and held it in 1 quarter. The position peaked at $421K in Q3 2024. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

  • Nomura Holdings reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Nomura Holdings sold 21,849 Syndax Pharmaceuticals shares in Q4 2024, an estimated $421K.
  • Nomura Holdings first reported a position in Syndax Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Nomura Holdings's Syndax Pharmaceuticals position peaked at $421K in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.